Endocan in hypertension and cardiovascular disease

Angiology

Volumn 65, Issue 9, 2014, Pages 757-759

  Whayne, Thomas F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; ESM1 PROTEIN, HUMAN; PROTEOGLYCAN; TUMOR PROTEIN;

BLOOD; FEMALE; HUMAN; HYPERTENSION; MALE; NOTE;

FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; MALE; NEOPLASM PROTEINS; PROTEOGLYCANS;

EID: 84907567621     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713514478     Document Type: Editorial

References (19)

1. Balta S, Mikhailidis DP, Demirkol S, et al. Endocan - a novel inflammatory indicator in newly diagnosed patients with hypertension: A pilot study. Angiology. 2014;65(9):773-777.
2. Lassalle P, Molet S, Janin A, et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271(34):20458-20464.
3. Pacher P, Mukhopadhyay P, Mohanraj R, Godlewski G, Batkai S, Kunos G. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension. 2008;52(4):601-607.
4. Adam E, Sarrazin S, Landolfi C, et al. Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor. Biochem Biophys Res Commun. 2008;369(2):297-302.
5. Abid MR, Yi X, Yano K, Shih SC, Aird WC. Vascular endocan is preferentially expressed in tumor endothelium. Microvasc Res. 2006;72(3):136-145.
6. Akkök CA, Hervig T, Stamnesfet S, et al. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 2011;13(10):1259-1268.
7. Rennel E, Mellberg S, Dimberg A, et al. Endocan is a VEGF-A and PI3 K regulated gene with increased expression in human renal cancer. Exp Cell Res. 2007;313(7):1285-1294.
8. Zuo L, Zhang SM, Hu RL, et al. Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol. 2008;14(28):4562-4568.
9. Zhang SM, Zuo L, Zhou Q, et al. Expression and distribution of endocan in human tissues. Biotech Histochem. 2012;87(3):172-178.
10. Roudnicky F, Poyet C, Wild P, et al. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013;73(3):1097-1106.
11. Leroy X, Aubert S, Zini L, et al. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 2010;56(2):180-187.
12. Hatfield KJ, Lassalle P, Leiva RA, Lindas R, Wendelboe O, Bruserud O. Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology. 2011;16(6):351-356.
13. Grigoriu BD, Depontieu F, Scherpereel A, et al. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res. 2006;12(15):4575-4582.
14. Chen LY, Liu X, Wang SL, Qin CY. Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res. 2010;38(2):498-510.
15. Scherpereel A, Gentina T, Grigoriu B, et al. Overexpression of endocan induces tumor formation. Cancer Res. 2003;63(18):6084-6089.
16. Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765(1):25-37.
17. Depontieu F, Grigoriu BD, Scherpereel A, et al. Loss of Endocan tumorigenic properties after alternative splicing of exon 2. BMC Cancer. 2008;8:14.
18. Balta I, Balta S, Demirkol S, et al. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013.
19. Balta I, Balta S, Koryurek OM, et al. Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol. 2013;169(5):1066-1070. doi: pii: S0190-9622(13)00964-X. 10.1016/j.jaad.2013.09.013.